Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Saint Petersburg State University Hospital, Saint Petersburg, Russian Federation
WonwangUH, Iksan, Please Select, Korea, Republic of
Tongji Hospital, Wuhan, Hubei, China
Cairo University, Cairo, Egypt
Fudan University Shanghai Cancer Center, Shanghai, China
Fudan University Shanghai Cancer Center, Shanghai, China
Faculty of medicine, Cairo University., Cairo, Egypt
Aculty of Medicine,Zagazig University, Zagazig, El Sharkia, Egypt
Wuhan Children's hospital, Wuhan, China
Department of Anesthesiology, The Second Xiangya Hospital, Changsha, Hunan, China
The Second Xiangya Hospital, Changsha, Hunan, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.